A Review of the CACNA Gene Family: Its Role in Neurological Disorders
- PMID: 38785745
- PMCID: PMC11119137
- DOI: 10.3390/diseases12050090
A Review of the CACNA Gene Family: Its Role in Neurological Disorders
Abstract
Calcium channels are specialized ion channels exhibiting selective permeability to calcium ions. Calcium channels, comprising voltage-dependent and ligand-gated types, are pivotal in neuronal function, with their dysregulation is implicated in various neurological disorders. This review delves into the significance of the CACNA genes, including CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1G, and CACNA1H, in the pathogenesis of conditions such as migraine, epilepsy, cerebellar ataxia, dystonia, and cerebellar atrophy. Specifically, variants in CACNA1A have been linked to familial hemiplegic migraine and epileptic seizures, underscoring its importance in neurological disease etiology. Furthermore, different genetic variants of CACNA1B have been associated with migraine susceptibility, further highlighting the role of CACNA genes in migraine pathology. The complex relationship between CACNA gene variants and neurological phenotypes, including focal seizures and ataxia, presents a variety of clinical manifestations of impaired calcium channel function. The aim of this article was to explore the role of CACNA genes in various neurological disorders, elucidating their significance in conditions such as migraine, epilepsy, and cerebellar ataxias. Further exploration of CACNA gene variants and their interactions with molecular factors, such as microRNAs, holds promise for advancing our understanding of genetic neurological disorders.
Keywords: CACNA genes; calcium channels; genetic variants; neurological disease.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11119137/bin/diseases-12-00090-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11119137/bin/diseases-12-00090-g002.gif)
Similar articles
-
CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options.Handb Exp Pharmacol. 2023;279:227-248. doi: 10.1007/164_2022_625. Handb Exp Pharmacol. 2023. PMID: 36592223 Review.
-
Mutations in the Voltage Dependent Calcium Channel CACNA1A (P/Q type alpha 1A subunit) Causing Neurological Disorders - An Overview.Neurol India. 2021 Jul-Aug;69(4):808-816. doi: 10.4103/0028-3886.325378. Neurol India. 2021. PMID: 34507393 Review.
-
Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes.Headache. 2017 Jul;57(7):1136-1144. doi: 10.1111/head.13107. Epub 2017 Jun 1. Headache. 2017. PMID: 28573794
-
CACNA1A-associated epilepsy: Electroclinical findings and treatment response on seizures in 18 patients.Eur J Paediatr Neurol. 2021 Jul;33:75-85. doi: 10.1016/j.ejpn.2021.05.010. Epub 2021 May 26. Eur J Paediatr Neurol. 2021. PMID: 34102571
-
Calcium channelopathies and intellectual disability: a systematic review.Orphanet J Rare Dis. 2021 May 13;16(1):219. doi: 10.1186/s13023-021-01850-0. Orphanet J Rare Dis. 2021. PMID: 33985586 Free PMC article. Review.
References
-
- Harrison P.J., Husain S.M., Lee H., De Los Angeles A., Colbourne L., Mould A., Hall N.A.L., Haerty W., Tunbridge E.M. CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology. Neuropharmacology. 2022;220:109262. doi: 10.1016/j.neuropharm.2022.109262. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources